Page 1 of 11

Dutasteride reduces risk of prostate carcinoma diagnosis in high-risk men

Dutasteride ( Avodart ) has shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease. The results are reported in the New England Journal of Medicine ( NEJM ). The four-year study found that Dutasteride significantly reduced the chances t...
Read Article

Routine cessation of Clopidogrel in patients before colonoscopy polypectomy is not necessary

Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted Clopidogrel ( Plavix ) and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while takin...
Read Article

Breast carcinoma patients with BRCA mutation diagnosed 6 years earlier than generation before

Women with a deleterious gene mutation are diagnosed with breast carcinoma six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer. The findings, presented in a poster session at the 2009 Breast Cancer Symposium, could have an impact on how women...
Read Article

Advanced non-small cell lung cancer: Vandetanib has shown clinical benefit when combined with Docetaxel

When combined with standard chemotherapy, Vandetanib ( Zactima ) improves progression-free survival for patients with advanced non-small cell lung cancer. The findings, presented at the American Society of Clinical Oncology's Annual Meeting, mark the first clinical benefit of a small molecule tar...
Read Article

Metastatic colon cancer: better surgical interventions, new chemotherapeutic and biological agents increase 5-year survival from 8 to 30 percent

Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease. Published in the Journal of Clinical Oncology, it is the first study in the last 20 y...
Read Article

Metastatic colorectal cancer: better surgical interventions, new chemotherapeutic and biological agents increase 5-year survival from 8 to 30 percent

Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease. Published in the Journal of Clinical Oncology, it is the first study in the last 20 y...
Read Article

Mammography may increase breast cancer risk in some high-risk women

Low-dose radiation from annual mammography screening may increase breast cancer risk in women with genetic or familial predisposition to breast cancer. According to Marijke C Jansen-van der Weide, at University Medical Center Groningen in the Netherlands, for women at high risk for breast cancer,...
Read Article

Metastatic HER2+ breast cancer: a combination of Capecitabine, Vinorelbine, and Trastuzumab is promising option

Combining two chemotherapy drugs with Trastuzumab ( Herceptin ) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options. At the 45th Annual Meeting of the American Society of Clinical Oncology ( ASCO ), researchers from the Mayo Clinic...
Read Article

Anti-angiogenesis inhibitors may improve outcomes of patients with sex cord-stromal tumors

Researchers at The University of Texas M. D. Anderson Cancer Center have found that increased angiogenesis and vascular endothelial growth factor expression are associated with poor survival in women with sex cord-stromal ovarian tumors. This data was presented at the Society of Gynecologic Oncol...
Read Article

Rituximab significantly reduces kidney injury in membranous nephropathy

Rituximab ( MabThera, Rituxan ) causes considerable kidney injury healing in patients with membranous nephropathy, a common form of kidney disease, according to a study published in the Clinical Journal of the American Society Nephrology ( CJASN ). The results suggest that this condition, previously...
Read Article